Growth Insights in APAC Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2023

Growth Insights in APAC Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2023

The Rising Prevalence of TB, HIV, and Hepatitis, Accompanied by the Development of Portable POCT Devices will Propel the APAC Infectious Diseases POCT Market

RELEASE DATE
07-Jun-2019
REGION
Asia Pacific
Research Code: PA00-01-00-00-00
SKU: HC03171-AP-MR_23119

$3,000.00

Special Price $2,250.00 save 25 %

In stock
SKU
HC03171-AP-MR_23119

$3,000.00

$2,250.00 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests.

The Asia-Pacific shows the highest prevalence of infectious diseases, such as tuberculosis (TB), hepatitis, and sexually transmitted infections (STIs). Countries such as India, China, and Indonesia are some of the leading contributors to these life-threatening infections. Hence, the Asia-Pacific stands out as a key contributor to the global infectious diseases diagnostics market.

With the rising disease prevalence, companies are shifting their business models to a more consumer-oriented approach. Steps are being taken to ensure a direct contact with the consumer/end user by means of direct-to-consumer selling using ecommerce portals such as Amazon. Alongside retail selling, vendors such as Alibaba ensure a bulk dispatch of diagnostic devices to hospitals and clinics, thereby playing a crucial role in the diagnostic value chain. The study also highlights some of the innovative payment models which result in improved patient access to these high value therapies. Information on some of the emerging business models across the cell therapy market, such as risk sharing, fast to market business models, etc., has also been provided.

Key Features

The study aims to identify some of the key growth opportunities which are set to drive the market in the next few years. It provides a revenue analysis of the total Asia-Pacific infectious diseases POCT market with an analysis of the specific regional players as well as the most common infectious disease diagnostics. The study also highlights some of the key market drivers and restraints which affect the growth. Additionally, it gives an insight on the leading market trends shaping the industry and their long-term implications on market growth. It also focuses on some of the country-specific regulatory policies and their impact on the adoption of innovative diagnostics solutions.


Key Issues Addressed

  • What are the biggest opportunities for companies in the infectious disease point-of-care testing space?
  • How are the various countries within the Asia-Pacific positioned to monetize the market opportunities?
  • What is the total market size and projected growth of POCT solutions for infectious diseases?
  • What are the key success factors for companies to remain relevant and competitive in this market?
  • How are product offerings in this market likely to emerge? How are transitions taking place across the value chain to solve the unmet needs from customers?

Table of Contents

Key Findings

Key Findings (continued)

Executive Summary—Market Engineering Measurements

Scope and Segmentation

Key Questions Addressed in this Study

6 Big Themes for the Infectious Disease POCT Market of the Future

Market Background and Overview

Value Chain Analysis

Value Chain Analysis (continued)

Technology Trends in the APAC Infectious Diseases POCT Market

Key Trends and Impact on Business

Technology Initiatives for Infectious Disease Diagnosis in APAC

Where is the Market Heading?

Market Analysis

Infectious Diseases Surveillance in APAC

Regional Perspectives for Infectious POCT Market in APAC—Top 5 Countries

Key Healthcare Reforms in China—Timeline

POCT in China—Market Dynamics

POCT in Japan—Market Dynamics

Tuberculosis Programmes in Southeast Asia

Market Engineering Measurements

Revenue Forecast Assumptions

Revenue Forecast

Revenue Forecast Discussion

Market Opportunity by Disease Area

Snapshot of Market Participants

Snapshot of Market Participants (continued)

Market Share Analysis

Key Companies to Watch

Key Companies to Watch (continued)

Competitive Environment

Competitive Factors Assessment

Competitive Benchmarking—POCT Solution Providers

Competitive Benchmarking—POCT Solution Providers (continued)

Key Mergers, Acquisitions, and Partnership Assessment

Visioning Scenarios for the Infectious Disease POCT Market

Business Models–Business to business to consumer (B2B2C) Models

Emerging Business Models—D2B2C* Models

Transformation in Industry Ecosystem

4 Major Growth Opportunities

Growth Opportunity 1—Affordable POC Tuberculosis Diagnostic Kit

Growth Opportunity 2—Growing Prevalence of Anti-microbial Resistance (AMR) Infections

Growth Opportunity 3—Portable Real-time Diagnostic Machines

Growth Opportunity 4—Under-penetrated Indonesian Market

Strategic Imperatives for Success and Growth

The Last Word—Three Big Predictions

Legal Disclaimer

Abbreviations

List of Exhibits

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests. The Asia-Pacific shows the highest prevalence of infectious diseases, such as tuberculosis (TB), hepatitis, and sexually transmitted infections (STIs). Countries such as India, China, and Indonesia are some of the leading contributors to these life-threatening infections. Hence, the Asia-Pacific stands out as a key contributor to the global infectious diseases diagnostics market. With the rising disease prevalence, companies are shifting their business models to a more consumer-oriented approach. Steps are being taken to ensure a direct contact with the consumer/end user by means of direct-to-consumer selling using ecommerce portals such as Amazon. Alongside retail selling, vendors such as Alibaba ensure a bulk dispatch of diagnostic devices to hospitals and clinics, thereby playing a crucial role in the diagnostic value chain. The study also highlights some of the innovative payment models which result in improved patient access to these high value therapies. Information on some of the emerging business models across the cell therapy market, such as risk sharing, fast to market business models, etc., has also been provided.--BEGIN PROMO--

Key Features

The study aims to identify some of the key growth opportunities which are set to drive the market in the next few years. It provides a revenue analysis of the total Asia-Pacific infectious diseases POCT market with an analysis of the specific regional players as well as the most common infectious disease diagnostics. The study also highlights some of the key market drivers and restraints which affect the growth. Additionally, it gives an insight on the leading market trends shaping the industry and their long-term implications on market growth. It also focuses on some of the country-specific regulatory policies and their impact on the adoption of innovative diagnostics solutions.

Key Issues Addressed

  • What are the biggest opportunities for companies in the infectious disease point-of-care testing space?
  • How are the various countries within the Asia-Pacific positioned to monetize the market opportunities?
  • What is the total market size and projected growth of POCT solutions for infectious diseases?
  • What are the key success factors for companies to remain relevant and competitive in this market?
  • How are product offerings in this market likely to emerge? How are transitions taking place across the value chain to solve the unmet needs from customers?
More Information
No Index No
Podcast No
Author Aarti Chitale
Industries Healthcare
WIP Number PA00-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,99C6-B1,9627-B1